
Integral Molecular Out-Licenses First-in-Class Antibody Panel Targeting SLC2A4 Glucose Transporter
PHILADELPHIA, June 17, 2025 /PRNewswire/ -- Integral Molecular, the industry leader in discovering antibodies against membrane proteins, is pleased to announce that it has out-licensed a panel of highly selective antibodies for the glucose …